Executive Summary
Imperative Care’s petition to invalidate Inari Medical’s hemostasis valve patent was granted. The Board found a reasonable likelihood of success on anticipation and obviousness grounds and instituted review of all nine claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Imperative Care, Inc. vs Inari Medical, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
SCOUT ENERGY MANAGEMENT, LLC et al.vsPilot Intellectual Property, LLC et al.
Chevron and Scout filed a joint motion to stay Pilot's infringement suit while the PTAB reviews the disputed patent in IPR2024-00385. The district court granted the stay, administratively closing the case pending the PTAB's final written decision.
Wise PLC et al.vs--
Wise PLC and Intercurrency Software LLC entered a settlement that grants Wise a royalty‑free license to several patents, includes a covenant not to sue, and results in the dismissal of both the related lawsuit and the IPR proceeding.
Anker Innovations Ltd.vsPowermat Technologies Ltd.
Anker Innovations Ltd. successfully convinced the PTAB to institute IPR proceedings against Powermat Technologies Ltd.'s patent (8626461). The Board found a reasonable likelihood of prevailing on anticipation and obviousness grounds regarding inductive power coupling technology.
Meta Platforms, Inc.vsSitnet, LLC
Meta Platforms successfully petitioned the PTAB to challenge Sitnet's patent (11470682) on grounds of obviousness over multiple prior art references. The Board granted institution, allowing Meta to proceed with its IPR challenge against claims 1-20.
Texas Instruments IncorporatedvsParkerVision, Inc.
Texas Instruments (TI) successfully secured the institution of its IPR against ParkerVision, Inc., establishing a reasonable likelihood of prevailing on obviousness grounds. The Board found that TI's evidence was sufficient at this stage to overcome arguments regarding inherency and simulation data reliability.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.